GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » C-Rad AB (LTS:0R44) » Definitions » Beneish M-Score

C-Rad AB (LTS:0R44) Beneish M-Score : -2.24 (As of Dec. 11, 2024)


View and export this data going back to 2014. Start your Free Trial

What is C-Rad AB Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.24 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for C-Rad AB's Beneish M-Score or its related term are showing as below:

LTS:0R44' s Beneish M-Score Range Over the Past 10 Years
Min: -3.66   Med: -2.13   Max: -0.83
Current: -2.24

During the past 13 years, the highest Beneish M-Score of C-Rad AB was -0.83. The lowest was -3.66. And the median was -2.13.


C-Rad AB Beneish M-Score Historical Data

The historical data trend for C-Rad AB's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C-Rad AB Beneish M-Score Chart

C-Rad AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.66 -2.20 -2.12 -2.56 -2.04

C-Rad AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.92 -2.04 -2.27 -2.45 -2.24

Competitive Comparison of C-Rad AB's Beneish M-Score

For the Medical Devices subindustry, C-Rad AB's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C-Rad AB's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, C-Rad AB's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where C-Rad AB's Beneish M-Score falls into.



C-Rad AB Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of C-Rad AB for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8917+0.528 * 0.9425+0.404 * 0.8706+0.892 * 1.262+0.115 * 1.5939
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1+4.679 * 0.022986-0.327 * 0.9701
=-2.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Total Receivables was kr223.6 Mil.
Revenue was 100.1 + 129.4 + 118 + 138.415 = kr485.9 Mil.
Gross Profit was 72.7 + 89.3 + 76.6 + 103.125 = kr341.7 Mil.
Total Current Assets was kr399.4 Mil.
Total Assets was kr450.1 Mil.
Property, Plant and Equipment(Net PPE) was kr19.9 Mil.
Depreciation, Depletion and Amortization(DDA) was kr9.0 Mil.
Selling, General, & Admin. Expense(SGA) was kr0.0 Mil.
Total Current Liabilities was kr127.2 Mil.
Long-Term Debt & Capital Lease Obligation was kr10.3 Mil.
Net Income was 15.4 + 10.6 + 16 + 15.929 = kr57.9 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = kr0.0 Mil.
Cash Flow from Operations was -17.2 + -2.6 + 16.6 + 50.783 = kr47.6 Mil.
Total Receivables was kr198.7 Mil.
Revenue was 111.2 + 90.6 + 84.4 + 98.826 = kr385.0 Mil.
Gross Profit was 71.9 + 59.7 + 55 + 68.602 = kr255.2 Mil.
Total Current Assets was kr342.4 Mil.
Total Assets was kr381.7 Mil.
Property, Plant and Equipment(Net PPE) was kr9.3 Mil.
Depreciation, Depletion and Amortization(DDA) was kr9.1 Mil.
Selling, General, & Admin. Expense(SGA) was kr0.0 Mil.
Total Current Liabilities was kr116.8 Mil.
Long-Term Debt & Capital Lease Obligation was kr3.4 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(223.6 / 485.915) / (198.7 / 385.026)
=0.460163 / 0.516069
=0.8917

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(255.202 / 385.026) / (341.725 / 485.915)
=0.662818 / 0.703261
=0.9425

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (399.4 + 19.9) / 450.1) / (1 - (342.4 + 9.3) / 381.7)
=0.068429 / 0.078596
=0.8706

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=485.915 / 385.026
=1.262

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(9.112 / (9.112 + 9.3)) / (8.961 / (8.961 + 19.9))
=0.494895 / 0.310488
=1.5939

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 485.915) / (0 / 385.026)
=0 / 0
=1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((10.3 + 127.2) / 450.1) / ((3.4 + 116.8) / 381.7)
=0.305488 / 0.314907
=0.9701

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(57.929 - 0 - 47.583) / 450.1
=0.022986

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

C-Rad AB has a M-score of -2.24 suggests that the company is unlikely to be a manipulator.


C-Rad AB Beneish M-Score Related Terms

Thank you for viewing the detailed overview of C-Rad AB's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


C-Rad AB Business Description

Traded in Other Exchanges
Address
Sjukhusvagen 12K, Uppsala, SWE, 753 09
C-Rad AB is a Sweden-based company engaged in the development and sales of systems with applications in radiation therapy for the treatment of cancer. The systems can be used to position the patient before the treatment and to localize and monitor the tumor by recording information such as patient movements during radiation treatment. Its product portfolio includes the Catalyst and Sentinel systems. Geographically, the company generates a majority of its revenue from Europe, Middle East and Africa and the rest from Americas and Asia Pacific region.

C-Rad AB Headlines

No Headlines